ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,752Medicare Part D Prescriptions Filled, Including Refills

Rank: 397 out of 1499

$398K Total Retail Price of All Prescriptions

Rank: 492 out of 1499

513 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 513 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 513 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

5% of this provider’s 6,239 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
AMLODIPINE BESYLATE 353 318 1 6
LOVASTATIN 318 271 2 19
LISINOPRIL 283 173 3 1
OMEPRAZOLE 248 178 4 5
LEVOTHYROXINE SODIUM 247 204 5 2
HYDROCODONE-ACETAMINOPHEN 233 161 S3 6 4
METFORMIN HCL 201 136 7 8
SIMVASTATIN 167 142 8 3
CITALOPRAM HBR 157 103 9 14
GABAPENTIN 149 95 10 13
SPIRONOLACTONE-HCTZ 130 109 11 237
WARFARIN SODIUM 122 101 12 12
HYDROCHLOROTHIAZIDE 122 94 12 9
PRAVASTATIN SODIUM 121 76 14 18
TRAMADOL HCL 116 76 15 16
LOSARTAN POTASSIUM 114 111 16 26
MELOXICAM 103 76 17 27
TRAZODONE HCL 103 71 17 32
ENALAPRIL MALEATE 100 88 19 75
AMITRIPTYLINE HCL 96 68 R 20 49
GLIMEPIRIDE 92 77 21 38
FLUOXETINE HCL 89 58 22 43
FUROSEMIDE 88 52 23 7
ZOLPIDEM TARTRATE 86 75 24 23
METOPROLOL SUCCINATE 85 56 25 20
POTASSIUM CHLORIDE 84 60 26 11
ATORVASTATIN CALCIUM 80 64 27 17
GLYBURIDE-METFORMIN HCL 78 40 R 28 165
CYCLOBENZAPRINE HCL 78 39 R 28 41
METOPROLOL TARTRATE 77 61 30 10
SERTRALINE HCL 77 60 30 24
FLUTICASONE PROPIONATE 77 46 30 31
ALENDRONATE SODIUM 75 68 33 33
CLOPIDOGREL 71 40 34 39
ESTRADIOL 70 40 R 35 130
PANTOPRAZOLE SODIUM 69 54 36 48
LISINOPRIL-HYDROCHLOROTHIAZIDE 66 49 37 25
GLYBURIDE 64 58 R 38 69
ATENOLOL 62 21 39 21
ATENOLOL-CHLORTHALIDONE 61 51 40 227
DONEPEZIL HCL 58 56 41 35
PREDNISONE 55 47 42 42
CRESTOR 54 28 43 34
PAROXETINE HCL 53 43 44 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 13, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.